RDHL has been in the news 500% more than usual
Nov 05, 2025, 1:34 PM
5.36%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: RedHill Biopharma Ltd. successfully secured over $10.5 million from the New York Supreme Court against Kukbo Co. Ltd., with no further appeals allowed. Additionally, LakeShore Biopharma is set to merge with Oceanpine Skyline Inc. in a deal valued at approximately $37 million.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.